Support Government of Kenya in accelerated transition of oversight and implementation of comprehensive HIV prevention and treatment programs for sustained epidemic control in the Republic of Kenya under PEPFAR

The Centers for Disease Control and Prevention, through its Global HIV and TB Branch (CDC-GHC), has released a forecasted cooperative agreement opportunity titled "Support Government of Kenya in accelerated transition of oversight and implementation of comprehensive HIV prevention and treatment programs for sustained epidemic control in the Republic of Kenya under PEPFAR." This funding is part of the U.S. Department of Health and Human Services portfolio and is supported under the President’s Emergency Plan for AIDS Relief (PEPFAR). The program reflects U.S. government commitment to strengthen the Government of Kenya’s capacity to sustain comprehensive HIV prevention, testing, and treatment programs in alignment with Kenya’s national health strategies. The purpose of this funding opportunity is to accelerate the transition of HIV program oversight and implementation to Kenya’s national and sub-national health systems. The focus is to strengthen local leadership, improve governance, and enhance sustainable financing mechanisms. Core program objectives include increasing national ownership of HIV service delivery, advancing capacity-building efforts for health systems, and ensuring the integration of HIV services into existing public health infrastructure. Activities supported under this opportunity include technical assistance, direct HIV prevention and treatment interventions, data-driven quality improvements, and strengthening accountability mechanisms across health sectors. The scope of the award is broad, covering HIV prevention, testing, treatment, and viral load suppression initiatives. The cooperative agreement will emphasize client-centered and evidence-based service delivery. Acceptable expenditures will likely include programmatic activities that build local institutional capacity, workforce development for HIV-related health professionals, and system strengthening to ensure continuity of care and improved outcomes. While funding is aligned with health services, it also supports activities related to governance, community engagement, and integration of HIV services into primary healthcare delivery. Eligibility for this opportunity is wide-ranging and includes state governments, county governments, city or township governments, special district governments, public housing authorities, independent school districts, Native American tribal governments and organizations, nonprofits with and without IRS 501(c)(3) status, for-profit organizations (including small businesses), private institutions of higher education, public and state-controlled institutions of higher education, and others. The eligibility criteria reflect an intent to attract a diverse set of potential applicants capable of supporting Kenya’s HIV epidemic control efforts through different mechanisms and expertise. The anticipated total fiscal year 2026 funding for the first year of this program is approximately $36.6 million, although the forecast lists the award ceiling and floor as zero. This indicates that finalized funding limits are not yet available, and applicants should monitor Grants.gov for updates when the full Notice of Funding Opportunity is released. The CDC anticipates making two awards under this opportunity, with a project start date expected on September 30, 2026, following an award date of the same day. This is a forecast, meaning the Notice of Funding Opportunity has not yet been posted. The estimated application due date is February 17, 2026, with electronic submissions required no later than 11:59 pm Eastern Time. The estimated posting date is December 2, 2025. The archive date for the opportunity is March 19, 2026. Applications must be submitted electronically, and no pre-application requirements such as letters of intent or concept papers are listed in the forecast. The program does not require cost sharing or matching contributions. Interested applicants may direct inquiries to the CDC’s Division of Global HIV & TB at pepfarfoas@cdc.gov. Applicants should remain attentive to Grants.gov updates for the full solicitation, which will detail proposal requirements, evaluation criteria, and specific funding allocations.